Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history
Open Access
- 10 January 2015
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 45 (6) , 698-706
Abstract
Objective To define the contribution of maternal variables that influence the measured mean arterial pressure (MAP) in screening for pregnancy complications. Methods Maternal characteristics and medical history were recorded, and MAP was measured, in women with a singleton pregnancy attending for three routine hospital visits at 11 + 0 to 13 + 6 weeks, 19 + 0 to 24 + 6 weeks and 30 + 0 to 34 + 6 weeks or 35 + 0 to 37 + 6 weeks' gestation. For pregnancies delivering phenotypically normal live births or stillbirths at ≥ 24 weeks' gestation, variables from maternal demographic characteristics and medical history that are important in the prediction of MAP were determined from linear mixed‐effects multiple regression analysis. Results MAP was measured in 75 841 cases in the first trimester, 30 447 in the second trimester and 31 673 in the third trimester. Significant independent contributions to MAP were provided by gestational age, maternal age, weight, height, Afro‐Caribbean racial origin, cigarette smoking, family history of pre‐eclampsia (PE), history of PE in the previous pregnancy, interpregnancy interval, chronic hypertension and diabetes mellitus. The effects of some variables were similar, and for others differed, in the three different trimesters. Random‐effects multiple regression analysis was used to define the contribution of maternal variables that influence the measured MAP and express the values as multiples of the median (MoMs). The model was shown to provide an adequate fit of MoM values for all covariates, both in pregnancies that developed PE and in those without this complication. Conclusions A model was fitted to express the measured MAP as MoMs after adjustment for variables from maternal characteristics and medical history that affect this measurement. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.Keywords
Funding Information
- EU FP7 (601852)
- Fetal Medicine Foundation
This publication has 17 references indexed in Scilit:
- Competing risks model in screening for preeclampsia by maternal characteristics and medical historyAmerican Journal of Obstetrics and Gynecology, 2015
- Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical MarkersFetal Diagnosis and Therapy, 2012
- A Competing Risks Model in Early Screening for PreeclampsiaFetal Diagnosis and Therapy, 2012
- Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-AnalysisFetal Diagnosis and Therapy, 2012
- Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' GestationFetal Diagnosis and Therapy, 2012
- Screening for fetal aneuploidies at 11 to 13 weeksPrenatal Diagnosis, 2011
- Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early PregnancyObstetrics & Gynecology, 2010
- Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trialThe Lancet, 2009
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- A CRITICAL EVALUATION OF SONAR “CROWN‐RUMP LENGTH” MEASUREMENTSBJOG: An International Journal of Obstetrics & Gynaecology, 1975